Genprex Provides Clinical Update on Diabetes Gene Therapy Program
Go back to Genprex Provides Clinical Update on Diabetes Gene Therapy Program| (NASDAQ: GNPX) | Delayed: 0.67 +0.03 (4.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.64 | 52 Week High | $ | |||
| Open | $0.64 | 52 Week Low | $ | |||
| Day High | $0.67 | P/E | N/A | |||
| Day Low | $0.62 | EPS | $ | |||
| Volume | 109,573 | |||||

